Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

WHO launches framework to monitor non-communicable diseases

Will measure success of efforts to reduce rates of cancer, diabetes, lung conditions and heart disease

Government accused of blocking patients from drug pricing talks

Coalition of cancer charities calls for a central role in pricing negotiations

Cancer Research UK appoints new head of public affairs and campaigning

Layla Theiner will drive the charity’s public affairs and campaigning activities across the UK and EU

- PMLiVE

Medicines key to new NHS Mandate, says ABPI

Government sets objectives for NHS Commissioning Board to improve patient care in England

Roche, social media and patients – part 1

UK pharma company talks about its digital patient group summit Share+

- PMLiVE

Merck & Co stops development of Januvia, atorvastatin combo

Company spokesperson claims decision is for “business reasons”

german flag

AZ sees Seroquel XR patent overturned in Germany

Follows challenge by Teva, Hexal and Accord Healthcare

- PMLiVE

Lilly takes Xeljanz rival baricitinib into phase III

Its partner Incyte says baricitinib could become the number one JAK inhibitor for RA

Road wins UK asthma treatment brief

Virginia Medical Supplies to launch Salin Plus ventilator in the UK

- PMLiVE

Peter Chambre joins cancer vaccine biotech Immatics

He replaces Thomas Widmann as chair of the board

- PMLiVE

Phlexglobal appoints Peter McNaney as CTO

He joins the trial master file technology company from Clinical Solutions

- PMLiVE

First mover advantage: ASCO 2012

Companies with enhanced strategic planning and careful forethought in structuring clinical trials will maximise opportunities in the oncology market

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links